Research & Development: Page 61

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Electronic Records: Beneficial to All, But At a Price

    The next five years will represent significant growth toward the implementation of electronic medical records (EMRs) in both hospitals and physician offices. Several ­factors are driving this new momentum, including the recent release of Notice for Proposed Rulemaking on the electronic health rec...

    By Robin Robinson • April 28, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Getting the Most From Distance Learning: Mistakes to Avoid

    It’s no secret that the use of distance learning is on the rise. As the economy remains shaky and budgets remain tight, pharmaceutical company training departments are working diligently to squeeze every drop of value from each dollar they spend. Training teams know that distance learning can hel...

    By PharmaVoice Team • April 28, 2010
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Kristin PECK Pfizer Names Head of Business ­Development Global healthcare company Pfizer has named Kristin Peck to succeed the retiring William Ringo as senior VP of worldwide business development, strategy, and innovation. Ms. Peck joined Pfizer’s strategic planning organizat...

    By PharmaVoice Team • April 28, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Most Doctors Prefer CME Promotion by E-mail Pharma Advised to Focus Social Media Efforts on Education Pharma Ramps Up ­Regulatory Affairs Delivering Articulate ­Message Key to ­Managed Markets Access Sidebar: Q. Which of...

    By PharmaVoice Team • April 28, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: BioClinica Launches System for Clinical-Trial ­Supply Planning New Quintiles Tool Accelerates Trial Recruitment Sidus Group Adds Life-Sciences Hosting ­Solution Paragon, NextDocs Collaborate on Clinical ­Optimizat...

    By PharmaVoice Team • April 28, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies Featured Briefs: TGaS Model Helps Solve Managed Markets Staffing Dilemma Razorfish Launches Independent, ­Dedicated Health Division FDA, NIH Collaborate to Speed Release of Medical Innovations Sidebar: On The Shelves PSKW Adds Loyalty Relat...

    By PharmaVoice Team • April 28, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Case Study: EpiCept

    Named Patient Programs Provide Pre-Launch Access to Drugs The dire outlook facing AML patients motivated a company to provide its drug in advance of the commercial launch. Jack V. Talley President and CEO, ­EpiCept EpiCept is a specialty pharmaceutical company that focuses on fulfilling unmet med...

    By Jack V. Talley President and CEO • April 28, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Market Report U.S. Prescription Sales Grow U.S. sales of ethical ­pharmaceuticals and insulins through retail and non-retail channels grew 5.1% in 2009, reaching $300.3 billion, ­compared with growth of 1.8% in 2008. While the 32 innovative products launched last year brought important new treatm...

    By PharmaVoice Team • April 28, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    10 Molecule to Market The drug development process from lead generation to patent expiration is complex, fraught with risk, and extremely time and cost intensive. 16 Drug Discovery Pharmaceutical companies are using state-of-the-art technologies to understand the basis of disease as a way to brin...

    By PharmaVoice Team • April 5, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Contents

    4 Ap r i l 201 0 Pharm aVOICE 34 James Sapirstein: Steering a Winning Course Managing a biotech company through the myriad obstacles companies face is difficult at the best of times; today it is much more taxing. James Sapirstein is proving that he has what it takes to put Tobira Therapeutics on ...

    By PharmaVoice Team • March 23, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: IRBs

    In accordance with federal regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. This review serves an important role in the protection of the rights and welfare of human research subjects. According to the Consortium of Independe...

    By PharmaVoice Team • March 23, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Brand Management: Using Market Research To Master Multichannel Challenges

    It’s a noisy, cluttered, and competitive market out there, with consumers receiving more messages from more channels — so how can a brand stand out? Everyone knows the right-right–right rule (right message at the right time to the right target), but in today’s environment, every moment represents...

    By PharmaVoice Team • March 23, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Specialty CROs: Market Opportunities

    The need for efficient drug development, as well as advances in technology and medical research, have spurred the growth of the smaller, more focused contract research organizations. These smaller CROs may offer preclinical and early-stage clinical research services such as toxicology, process de...

    By PharmaVoice Team • March 23, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    The Acquisition by Medco What does DNA Direct bring to Medco? PHELAN. Medco’s healthcare clients, whether they are large self-insured employers or health plans, are all looking for better patient outcomes and quality of service, as well as reduced costs. DNA Direct helps with the interpretation o...

    By PharmaVoice Team • March 23, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Jay FEINGOLD DSI Strengthens Expertise in Oncology Daiichi Sankyo Inc. (DSI) has appointed Jay Feingold, M.D., Ph.D., to manage the strategic direction of its medical affairs department as VP of medical affairs. DSI is the U.S. subsidiary of Tokyo-based Daiichi Sankyo Co.,...

    By PharmaVoice Team • March 22, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies Featured Briefs: CMR Institute Broadens Curriculum to Offer Targeted Educational ­Solutions MedTera Specializes in Integrated Healthcare Marketing Mayo Clinic Collaborates with Centerphase to Provide Clinical-Trial Services Velocity Offers ...

    By PharmaVoice Team • March 22, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Intrasphere Solution Keeps Pace with ­Clinical Trial ­Disclosure Requirements New Tool Measures Sales Team’s Grasp of Managed Markets Concepts PPD Unveils Centralized Biostatistics ­Technology Infrastructure Model...

    By PharmaVoice Team • March 22, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    More Consumers Going Online for ­Pharma Info The number of people using the Internet to obtain information on prescription drugs has tripled over the past five years, and more than 100 million consumers, or 44% of U.S. adults, are now what Manhattan Research terms “ePharma Consumers." According t...

    By PharmaVoice Team • March 22, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Honors and Awards Kendle, Quintiles Named to ­Training Top 125 Kendle and Quintiles have been named to Training magazine’s Training Top 125, an annual list of the 125 companies that are unsurpassed in harnessing human capital. The Training Top 125 rankings are based on a wide array of benchmarkin...

    By PharmaVoice Team • March 22, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Ahhh sweet spring… There are a few among us who are no doubt wishing for one more super snow storm (a couple I know very well), but for most of us in the Northeast who have been buried under feet of snow for most of the winter, we couldn’t be more excited to see the first signs of spring, well…sp...

    By PharmaVoice Team • March 22, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Molecule to Market: A Drug-Development Timeline

    According to the most recent report from the Tufts Center for the Study of Drug Development, it takes about 10 years on average for an experimental drug to travel from the lab to U.S. patients. Only five in 5,000 compounds that enter preclinical testing make it to human testing, and of these five...

    By Taren Grom • March 5, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Experts

    John C. Andrews, Ph.D. Director of Regulatory Affairs, Americas, Chiltern, a global CRO. For more information, visit chiltern.com. Jerome Bailey. VP, Early Phase Business Center, Omnicare Clinical Research, a full-service CRO with diverse therapeutic expertise and comprehensive clinical service o...

    By PharmaVoice Team • March 4, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Phase IV: Technology Solutions

    According to John Hall, global medical affairs, epidemiology and outcomes research, at Quintiles, electronic health record providers are at the leading edge of new solutions, and are providing more effective ways to collect data while protecting physician relationships. The industry faces several...

    By Robin Robinson • March 4, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Phase III: Market Preparation

    How the brand begins to be positioned across the spectrum of medical communications — specifically how the science behind the brand and trial results begin to be discussed at global and local congresses, from interactive and traditional exhibit stands to symposia, from posters to special social e...

    By Robin Robinson • March 4, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Phase III Trials: Patient Recruitment and Data Collection

    Two of the biggest bottlenecks in the drug development process, particularly at the Phase III juncture, are patient recruitment and data management. Experts say technology, partnering, and strategic planning can improve Phase III clinical trial efficiency. Phase III: Recruitment ­Technologies Acc...

    By Robin Robinson • March 4, 2010